Read More

deCODE Genetics, A Subsidiary Of Amgen, Has Published A Study In The New England Journal Of Medicine, On Actionable Genotypes Detected In The Icelandic Population And Their Association With Lifespan

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan. The results of this study are among the

AMGN

Read More

INmune Bio Inc. Announces Expansion Of Phase II Clinical Trial For Alzheimer’s Disease In Europe; The Company Received A Cash Refund Of ~$2.8M Pursuant To An Australian Research And Development Tax Incentive

The Company received a cash refund of approximately $2.8M USD pursuant to an Australian Research and Development Tax Incentive.Boca Raton, Florida, Nov. 15, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB)

INMB